Home/SciSparc/Oz Adler
OA

Oz Adler

Chief Executive Officer

SciSparc

Therapeutic Areas

SciSparc Pipeline

DrugIndicationPhase
SCI-110Tourette SyndromePhase IIb
SCI-160Chronic PainPreclinical
SCI-210Autism Spectrum Disorder (ASD)Phase II